🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 23 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| 14/12/2022 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/05/2006 | 32,74 | 33,04 | 31,62 | 31,62 | -4,11% | 4,34% | 17.535.974 |
| 26/05/2006 | 32,90 | 33,43 | 32,89 | 32,98 | +0,49% | 1,62% | 10.064.049 |
| 25/05/2006 | 32,44 | 32,86 | 32,44 | 32,81 | +1,33% | 1,29% | 11.845.230 |
| 24/05/2006 | 32,68 | 33,04 | 32,34 | 32,39 | -1,45% | 2,16% | 11.553.990 |
| 23/05/2006 | 32,79 | 33,02 | 32,45 | 32,86 | +0,09% | 1,72% | 12.002.639 |
| 22/05/2006 | 32,75 | 33,02 | 32,73 | 32,83 | -0,03% | 0,90% | 13.181.325 |
| 19/05/2006 | 33,64 | 33,64 | 32,57 | 32,84 | -2,02% | 3,18% | 14.913.878 |
| 18/05/2006 | 32,96 | 33,72 | 32,81 | 33,52 | +2,30% | 2,78% | 16.253.642 |
| 17/05/2006 | 33,40 | 33,88 | 32,61 | 32,77 | -2,22% | 3,80% | 15.839.472 |
| 16/05/2006 | 33,25 | 33,78 | 33,21 | 33,51 | +1,24% | 1,72% | 9.349.837 |
| 15/05/2006 | 32,95 | 33,66 | 32,74 | 33,10 | +1,17% | 2,81% | 10.825.735 |
| 12/05/2006 | 32,90 | 33,23 | 32,61 | 32,72 | -0,64% | 1,89% | 8.680.060 |
| 11/05/2006 | 33,02 | 33,29 | 32,83 | 32,93 | -0,46% | 1,39% | 7.619.379 |
| 10/05/2006 | 32,86 | 33,19 | 32,73 | 33,08 | +0,70% | 1,39% | 8.388.821 |
| 09/05/2006 | 32,87 | 33,34 | 32,76 | 32,85 | -0,06% | 1,77% | 8.888.402 |
| 08/05/2006 | 33,18 | 33,20 | 32,68 | 32,87 | -0,09% | 1,55% | 6.700.598 |
| 05/05/2006 | 32,86 | 32,97 | 32,48 | 32,90 | +0,50% | 1,48% | 7.374.042 |
| 04/05/2006 | 32,52 | 32,82 | 32,52 | 32,74 | +0,47% | 0,94% | 6.509.966 |
| 03/05/2006 | 32,92 | 33,09 | 32,50 | 32,59 | -0,96% | 1,80% | 7.982.616 |
| 02/05/2006 | 32,67 | 32,98 | 32,43 | 32,90 | +0,70% | 1,66% | 6.520.551 |
| 01/05/2006 | 33,08 | 33,25 | 32,49 | 32,67 | -0,52% | 2,31% | 7.840.088 |
| 28/04/2006 | 32,84 | 33,11 | 32,61 | 32,84 | -0,52% | 1,51% | 7.472.240 |
| 27/04/2006 | 32,44 | 33,34 | 32,44 | 33,02 | +0,82% | 2,76% | 6.814.725 |
| 26/04/2006 | 32,73 | 33,21 | 32,64 | 32,75 | +0,23% | 1,72% | 6.871.212 |
| 25/04/2006 | 32,72 | 32,81 | 32,35 | 32,67 | -0,38% | 1,43% | 5.759.284 |
| 24/04/2006 | 32,75 | 33,15 | 32,56 | 32,80 | -1,07% | 1,81% | 7.180.477 |
| 21/04/2006 | 33,58 | 33,58 | 32,68 | 33,15 | -0,74% | 2,67% | 12.059.755 |
| 20/04/2006 | 33,03 | 33,65 | 32,94 | 33,40 | +1,74% | 2,14% | 8.769.350 |
| 19/04/2006 | 32,87 | 33,19 | 32,65 | 32,82 | -0,23% | 1,63% | 6.627.657 |
| 18/04/2006 | 32,19 | 32,91 | 32,18 | 32,90 | +2,01% | 2,28% | 9.539.106 |